Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRYSTALLINE TOLTERODINE TARTARATE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
Document Type and Number:
WIPO Patent Application WO2008017278
Kind Code:
B1
Abstract:
A crystalline salt of 2-[(1R)-3-[bis(l-methylethyl)amino]-1-?henyl?ropyl]-4-methyl-phenol with (2R,3R)-2,3-dihydroxybutanedioic acid, known under the name R-tolterodine tartarate, wherein: a) at least 90 % of all crystals are present in a size smaller than 30 µm, b) at least 40 % of crystalline matter are smaller than 250 µm, c) the maximum size of crystals does not exceed 800 µm, d) the salt contains less than 0.1 weight % of the undesirable enantiomer S-tolterodine tartarate, e) analytical test for sulfate ashes (Pharm. Eur.) provides a value lower than 0.1%. The method of its preparation involves at least one crystallization from water. A pharmaceutical composition containing tolterodine or its pharmaceutically acceptable salts further contains a filler, a disintegrant and a lubricant, said composition being free of ions of alkaline earth metals.

Inventors:
SVOBODA MARTIN (CZ)
JAMPILEK JOSEF (CZ)
KACIRKOVA MARTINA (CZ)
TOMASEK VACLAV (CZ)
LEHOCKY MIKULAS (CZ)
HEJTMANKOVA LUDMILA (CZ)
VOSATKA VACLAV (CZ)
Application Number:
PCT/CZ2007/000078
Publication Date:
August 28, 2008
Filing Date:
August 09, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ZENTIVA AS (CZ)
SVOBODA MARTIN (CZ)
JAMPILEK JOSEF (CZ)
KACIRKOVA MARTINA (CZ)
TOMASEK VACLAV (CZ)
LEHOCKY MIKULAS (CZ)
HEJTMANKOVA LUDMILA (CZ)
VOSATKA VACLAV (CZ)
International Classes:
C07C213/10; A61K31/137; C07C215/54
Download PDF: